What is the projected market valuation of the Thoracic Surgery Market by 2035?

The Thoracic Surgery Market is projected to reach a valuation of 30.55 USD Billion by 2035. Read More

What was the market valuation of the Thoracic Surgery Market in 2024?

In 2024, the overall market valuation was 18.01 USD Billion. Read More

What is the expected CAGR for the Thoracic Surgery Market during the forecast period 2025 - 2035?

The expected CAGR for the Thoracic Surgery Market during the forecast period 2025 - 2035 is 4.92%. Read More

Which companies are considered key players in the Thoracic Surgery Market?

Key players in the Thoracic Surgery Market include Medtronic, Johnson & Johnson, Boston Scientific, and Stryker. Read More

What are the projected revenues for Open Thoracic Surgery by 2035?

The projected revenues for Open Thoracic Surgery are expected to reach 9.0 USD Billion by 2035. Read More

How does the revenue for Video-Assisted Thoracoscopic Surgery (VATS) compare to other procedures by 2035?

By 2035, Video-Assisted Thoracoscopic Surgery (VATS) is projected to generate revenues of 12.0 USD Billion, indicating strong growth. Read More

What is the expected revenue for lung cancer treatments in the Thoracic Surgery Market by 2035?

The expected revenue for lung cancer treatments in the Thoracic Surgery Market is projected to be 12.0 USD Billion by 2035. Read More

What segment of the Thoracic Surgery Market is anticipated to have the highest revenue growth?

The Therapeutic segment is anticipated to have the highest revenue growth, projected to reach 17.0 USD Billion by 2035. Read More

What is the revenue projection for inpatient thoracic surgeries by 2035?

Inpatient thoracic surgeries are projected to generate revenues of 17.0 USD Billion by 2035. Read More

What surgical approach is expected to see significant growth in the Thoracic Surgery Market?

The Minimally Invasive Approach is expected to see significant growth, with projected revenues of 13.55 USD Billion by 2035. Read More

Thoracic Surgery Market

ID: MRFR/HC/26215-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Thoracic Surgery Market Research Report By Procedure Type (Open Thoracic Surgery, Video-Assisted Thoracoscopic Surgery (VATS), Robotics-Assisted Thoracic Surgery (RATS)), By Medical Condition (Lung Cancer, Esophageal Cancer, Mediastinal Tumors, Pneumothorax, Empyema), By Patient Type (Inpatients, Outpatients), By Surgical Approach (Standard Approach, Minimally Invasive Approach), By Surgical Scope (Diagnostic, Therapeutic, Emergency) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Procedure Type (USD Billion)
  1. 4.1.1 Open Thoracic Surgery
  2. 4.1.2 Video-Assisted Thoracoscopic Surgery (VATS)
  3. 4.1.3 Robotics-Assisted Thoracic Surgery (RATS)
2. 4.2 Healthcare, BY Medical Condition (USD Billion)
  1. 4.2.1 Lung Cancer
  2. 4.2.2 Esophageal Cancer
  3. 4.2.3 Mediastinal Tumors
  4. 4.2.4 Pneumothorax
  5. 4.2.5 Empyema
3. 4.3 Healthcare, BY Patient Type (USD Billion)
  1. 4.3.1 Inpatients
  2. 4.3.2 Outpatients
4. 4.4 Healthcare, BY Surgical Approach (USD Billion)
  1. 4.4.1 Standard Approach
  2. 4.4.2 Minimally Invasive Approach
5. 4.5 Healthcare, BY Surgical Scope (USD Billion)
  1. 4.5.1 Diagnostic
  2. 4.5.2 Therapeutic
  3. 4.5.3 Emergency
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Johnson & Johnson (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Stryker (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Abbott Laboratories (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 B. Braun Melsungen AG (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Smith & Nephew (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Terumo Corporation (JP)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Intuitive Surgical (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY PROCEDURE TYPE
4. 6.4 US MARKET ANALYSIS BY MEDICAL CONDITION
5. 6.5 US MARKET ANALYSIS BY PATIENT TYPE
6. 6.6 US MARKET ANALYSIS BY SURGICAL APPROACH
7. 6.7 US MARKET ANALYSIS BY SURGICAL SCOPE
8. 6.8 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
9. 6.9 CANADA MARKET ANALYSIS BY MEDICAL CONDITION
10. 6.10 CANADA MARKET ANALYSIS BY PATIENT TYPE
11. 6.11 CANADA MARKET ANALYSIS BY SURGICAL APPROACH
12. 6.12 CANADA MARKET ANALYSIS BY SURGICAL SCOPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY MEDICAL CONDITION
16. 6.16 GERMANY MARKET ANALYSIS BY PATIENT TYPE
17. 6.17 GERMANY MARKET ANALYSIS BY SURGICAL APPROACH
18. 6.18 GERMANY MARKET ANALYSIS BY SURGICAL SCOPE
19. 6.19 UK MARKET ANALYSIS BY PROCEDURE TYPE
20. 6.20 UK MARKET ANALYSIS BY MEDICAL CONDITION
21. 6.21 UK MARKET ANALYSIS BY PATIENT TYPE
22. 6.22 UK MARKET ANALYSIS BY SURGICAL APPROACH
23. 6.23 UK MARKET ANALYSIS BY SURGICAL SCOPE
24. 6.24 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
25. 6.25 FRANCE MARKET ANALYSIS BY MEDICAL CONDITION
26. 6.26 FRANCE MARKET ANALYSIS BY PATIENT TYPE
27. 6.27 FRANCE MARKET ANALYSIS BY SURGICAL APPROACH
28. 6.28 FRANCE MARKET ANALYSIS BY SURGICAL SCOPE
29. 6.29 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
30. 6.30 RUSSIA MARKET ANALYSIS BY MEDICAL CONDITION
31. 6.31 RUSSIA MARKET ANALYSIS BY PATIENT TYPE
32. 6.32 RUSSIA MARKET ANALYSIS BY SURGICAL APPROACH
33. 6.33 RUSSIA MARKET ANALYSIS BY SURGICAL SCOPE
34. 6.34 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
35. 6.35 ITALY MARKET ANALYSIS BY MEDICAL CONDITION
36. 6.36 ITALY MARKET ANALYSIS BY PATIENT TYPE
37. 6.37 ITALY MARKET ANALYSIS BY SURGICAL APPROACH
38. 6.38 ITALY MARKET ANALYSIS BY SURGICAL SCOPE
39. 6.39 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
40. 6.40 SPAIN MARKET ANALYSIS BY MEDICAL CONDITION
41. 6.41 SPAIN MARKET ANALYSIS BY PATIENT TYPE
42. 6.42 SPAIN MARKET ANALYSIS BY SURGICAL APPROACH
43. 6.43 SPAIN MARKET ANALYSIS BY SURGICAL SCOPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY MEDICAL CONDITION
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY PATIENT TYPE
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY SURGICAL APPROACH
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY SURGICAL SCOPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
51. 6.51 CHINA MARKET ANALYSIS BY MEDICAL CONDITION
52. 6.52 CHINA MARKET ANALYSIS BY PATIENT TYPE
53. 6.53 CHINA MARKET ANALYSIS BY SURGICAL APPROACH
54. 6.54 CHINA MARKET ANALYSIS BY SURGICAL SCOPE
55. 6.55 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
56. 6.56 INDIA MARKET ANALYSIS BY MEDICAL CONDITION
57. 6.57 INDIA MARKET ANALYSIS BY PATIENT TYPE
58. 6.58 INDIA MARKET ANALYSIS BY SURGICAL APPROACH
59. 6.59 INDIA MARKET ANALYSIS BY SURGICAL SCOPE
60. 6.60 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
61. 6.61 JAPAN MARKET ANALYSIS BY MEDICAL CONDITION
62. 6.62 JAPAN MARKET ANALYSIS BY PATIENT TYPE
63. 6.63 JAPAN MARKET ANALYSIS BY SURGICAL APPROACH
64. 6.64 JAPAN MARKET ANALYSIS BY SURGICAL SCOPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY MEDICAL CONDITION
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY PATIENT TYPE
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY SURGICAL APPROACH
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY SURGICAL SCOPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
71. 6.71 MALAYSIA MARKET ANALYSIS BY MEDICAL CONDITION
72. 6.72 MALAYSIA MARKET ANALYSIS BY PATIENT TYPE
73. 6.73 MALAYSIA MARKET ANALYSIS BY SURGICAL APPROACH
74. 6.74 MALAYSIA MARKET ANALYSIS BY SURGICAL SCOPE
75. 6.75 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
76. 6.76 THAILAND MARKET ANALYSIS BY MEDICAL CONDITION
77. 6.77 THAILAND MARKET ANALYSIS BY PATIENT TYPE
78. 6.78 THAILAND MARKET ANALYSIS BY SURGICAL APPROACH
79. 6.79 THAILAND MARKET ANALYSIS BY SURGICAL SCOPE
80. 6.80 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
81. 6.81 INDONESIA MARKET ANALYSIS BY MEDICAL CONDITION
82. 6.82 INDONESIA MARKET ANALYSIS BY PATIENT TYPE
83. 6.83 INDONESIA MARKET ANALYSIS BY SURGICAL APPROACH
84. 6.84 INDONESIA MARKET ANALYSIS BY SURGICAL SCOPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
86. 6.86 REST OF APAC MARKET ANALYSIS BY MEDICAL CONDITION
87. 6.87 REST OF APAC MARKET ANALYSIS BY PATIENT TYPE
88. 6.88 REST OF APAC MARKET ANALYSIS BY SURGICAL APPROACH
89. 6.89 REST OF APAC MARKET ANALYSIS BY SURGICAL SCOPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
92. 6.92 BRAZIL MARKET ANALYSIS BY MEDICAL CONDITION
93. 6.93 BRAZIL MARKET ANALYSIS BY PATIENT TYPE
94. 6.94 BRAZIL MARKET ANALYSIS BY SURGICAL APPROACH
95. 6.95 BRAZIL MARKET ANALYSIS BY SURGICAL SCOPE
96. 6.96 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
97. 6.97 MEXICO MARKET ANALYSIS BY MEDICAL CONDITION
98. 6.98 MEXICO MARKET ANALYSIS BY PATIENT TYPE
99. 6.99 MEXICO MARKET ANALYSIS BY SURGICAL APPROACH
100. 6.100 MEXICO MARKET ANALYSIS BY SURGICAL SCOPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
102. 6.102 ARGENTINA MARKET ANALYSIS BY MEDICAL CONDITION
103. 6.103 ARGENTINA MARKET ANALYSIS BY PATIENT TYPE
104. 6.104 ARGENTINA MARKET ANALYSIS BY SURGICAL APPROACH
105. 6.105 ARGENTINA MARKET ANALYSIS BY SURGICAL SCOPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY MEDICAL CONDITION
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT TYPE
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL APPROACH
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL SCOPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY MEDICAL CONDITION
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY PATIENT TYPE
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL APPROACH
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL SCOPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY MEDICAL CONDITION
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY PATIENT TYPE
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL APPROACH
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL SCOPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
123. 6.123 REST OF MEA MARKET ANALYSIS BY MEDICAL CONDITION
124. 6.124 REST OF MEA MARKET ANALYSIS BY PATIENT TYPE
125. 6.125 REST OF MEA MARKET ANALYSIS BY SURGICAL APPROACH
126. 6.126 REST OF MEA MARKET ANALYSIS BY SURGICAL SCOPE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY MEDICAL CONDITION, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY MEDICAL CONDITION, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY SURGICAL APPROACH, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY SURGICAL APPROACH, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY SURGICAL SCOPE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY SURGICAL SCOPE, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.2.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.2.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.2.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.3.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.3.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.3.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.4.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.4.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.4.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.5.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.5.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.5.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.6.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.6.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.6.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.7.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.7.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.7.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.8.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.8.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.8.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.9.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.9.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.9.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.10.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.10.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.10.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.11.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.11.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.11.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.12.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.12.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.12.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.13.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.13.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.13.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.14.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.14.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.14.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.15.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.15.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.15.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.16.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.16.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.16.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.17.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.17.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.17.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.18.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.18.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.18.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.19.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.19.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.19.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.20.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.20.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.20.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.21.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.21.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.21.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.22.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.22.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.22.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.23.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.23.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.23.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.24.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.24.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.24.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.25.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.25.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.25.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.26.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.26.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.26.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.27.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.27.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.27.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.28.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.28.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.28.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.29.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.29.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.29.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY MEDICAL CONDITION, 2025-2035 (USD Billion)
  3. 7.30.3 BY PATIENT TYPE, 2025-2035 (USD Billion)
  4. 7.30.4 BY SURGICAL APPROACH, 2025-2035 (USD Billion)
  5. 7.30.5 BY SURGICAL SCOPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Procedure Type (USD Billion, 2025-2035)

Open Thoracic Surgery
Video-Assisted Thoracoscopic Surgery (VATS)
Robotics-Assisted Thoracic Surgery (RATS)

Healthcare By Medical Condition (USD Billion, 2025-2035)

Lung Cancer
Esophageal Cancer
Mediastinal Tumors
Pneumothorax
Empyema

Healthcare By Patient Type (USD Billion, 2025-2035)

Inpatients
Outpatients

Healthcare By Surgical Approach (USD Billion, 2025-2035)

Standard Approach
Minimally Invasive Approach

Healthcare By Surgical Scope (USD Billion, 2025-2035)

Diagnostic
Therapeutic
Emergency

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”